🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will assess the objective response rate (ORR), safety, progressi...
Status
Unknown
Location
Multiple Locations
Start Date
2022-06-01
Trial ID
NCT05346328
Treatments Being Tested
Open-label, Phase I-II, first-in-human (FIH) study for A166 monotherapy in ...
Status
Completed
Location
Florida Cancer Specialists & Research Institute
Start Date
2018-07-16
Trial ID
NCT03602079
Treatments Being Tested
Evaluation of the efficacy of A166 versus trastuzumab emtansine (T-DM1) in ...
Status
Active Not Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2023-07-18
Trial ID
NCT06968585
Evaluation of the efficacy of A166 in Patients with HER2-Positive unresecta...
Status
Recruiting
Location
Henan Provincial Cancer Hospital
Start Date
2024-09-20
Trial ID
NCT07299825
Treatments Being Tested
This is a single arm, open-label, dose-escalation and dose-expansion phase ...
Status
Active Not Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2018-08-09
Trial ID
NCT05311397
Treatments Being Tested